
AI-generated summary
It has been known that prolonged high-calorie conditions reduce brain function, but the mechanism at the molecular level was not understood.
A research team at Tokyo University of Science and others has revealed through experiments using mice that the decline in cognitive function caused by continued high-calorie diets is caused by abnormalities in synapses, the connections between nerve cells in the brain. It has been known that prolonged high-calorie conditions reduce brain function, but the detailed mechanism at the molecular level was not understood. The paper was published in an international scientific journal in September.
A research team led by Professor Hitoshi Okazawa of Tokyo University of Science fed mice a high-calorie diet for one or six weeks and compared the results at the molecular level with neurons in the regular diet group. As a result, it was found that a protein called "PQBP1" was decreased.
PQBP1 plays a role in regulating the correct production of proteins necessary for nerve cell information transmission. A detailed study revealed that in mice fed a high-calorie diet, insulin put a brake on the mechanism that produces PQBP1, causing abnormalities in the molecules that make up synapses and reducing the functioning of neural circuits.
When the research team administered anti-diabetic drugs and treatment to supplement PQBP1, synaptic abnormalities and cognitive function improved.
According to Professor Okazawa, further research may lead to the prevention of Alzheimer's disease in obese and diabetic patients.
AI outlook — possibilities, not facts
May help prevent Alzheimer's disease in obese and diabetic patients
Possible · Within months

A female employee at a plague control institute died in the Irkutsk Oblast in Eastern Siberia, Russia, and rumors spread that she had been infected, but Russian authorities are trying to put out the fire by claiming that no plague bacteria was detected in her samples.

The Japan Obesity Society has issued a recommendation calling for caution as there have been a number of cases of the diabetes drug Manjaro being inappropriately used for dieting purposes, resulting in health hazards such as impaired consciousness. It warns of the risk of ketosis when combined with excessive dietary restrictions.

With the second-fastest influenza outbreak on record, infections are also spreading in Kumamoto Prefecture, where people are still evacuated after the July earthquake. Experts are cautioning against crowds in evacuation centers, stressing the importance of washing hands and wearing masks, as well as getting vaccinated as soon as possible.

On the 28th, four academic societies, including the Japanese Society of Emergency Medicine, announced new guidelines for life-sustaining treatment for patients receiving emergency transport and intensive care. Rather than establishing a definition of end-of-life, it clarified the procedure for discussions between the medical team and the patient and family to decide on a policy, and also provided concrete guidance on palliative care after treatment is completed.

Eisai and Biogen announced on the 16th that they have received manufacturing and marketing approval from the Ministry of Health, Labor and Welfare for a subcutaneous injection formulation of the Alzheimer's disease treatment drug lecanemab. The drug can be self-administered once a week, which is expected to reduce the burden on patients.

Ahead of Respect for the Aged Day, the Ministry of Health, Labor and Welfare announced that the number of people aged 100 or older nationwide has reached 107,677, setting a record high for the 56th consecutive year. Nearly 90% of the participants are women, and the oldest in Japan are Fuyo Kishimoto (Kyoto City), 114 years old, and Hikaru Kato (Kumamoto City), 112 years old. Shimane Prefecture has the highest number of cases per 100,000 people and has been at the top for 14 consecutive years.